XML 63 R33.htm IDEA: XBRL DOCUMENT v3.25.3
Fair Value of Financial Instruments (Tables)
3 Months Ended
Sep. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value
The following table summarizes the valuation of the Company’s remaining assets and liabilities measured at fair value on a recurring basis at September 30, 2025:
TotalQuoted
prices in
active
markets
(Level 1)
Significant
other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
 (in thousands)
Assets:
Deferred compensation plan investments, current and non-current$35,388 $35,388 $ $ 
Interest rate swap agreement373  373  
Total assets at fair value$35,761 $35,388 $373 $ 
Liabilities:
Deferred compensation plan investments, current and non-current$35,388 $35,388 $ $ 
Forward foreign currency exchange contracts6  6  
Foreign currency hedge89  89  
Liability for contingent consideration, current and non-current18,039   18,039 
Total liabilities at fair value$53,522 $35,388 $95 $18,039 
The following table summarizes the valuation of the Company’s remaining assets and liabilities measured at fair value on a recurring basis at June 30, 2025:
TotalQuoted
prices in
active
markets
(Level 1)
Significant
other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
 (in thousands)
Assets:
Deferred compensation plan investments, current and non-current $31,887 $31,887 $— $— 
Forward foreign currency exchange contracts15 — 15 — 
Interest rate swap agreement680 — 680 — 
Total assets at fair value$32,582 $31,887 $695 $— 
Liabilities:
Deferred compensation plan investments, current and non-current$31,887 $31,887 $— $— 
Foreign currency hedge290 — 290 — 
Liability for contingent consideration, current and non-current19,100 — — 19,100 
Total liabilities at fair value$51,277 $31,887 $290 $19,100 
Schedule of Changes in Fair Value of Contingent Considerations
The following tables summarizes the fair value of the Company's contingent consideration liabilities at September 30, 2025 and September 30, 2024:
Contingent consideration for the quarter ended
September 30, 2025
 Specialty Technology SolutionsIntelisys & AdvisoryTotal
 (in thousands)
Fair value at beginning of period$6,660 $12,440 $19,100 
Payments(1,375) (1,375)
Change in fair value of contingent consideration145 169 314 
Fair value at end of period$5,430 $12,609 $18,039 
Contingent consideration for the quarter ended
September 30, 2024
 Specialty Technology SolutionsIntelisys & AdvisoryTotal
 (in thousands)
Fair value at beginning of period$— $— $— 
Issuance of contingent consideration7,500 9,700 17,200 
Fair value at end of period$7,500 $9,700 $17,200 
Valuation techniques and significant observable inputs used in recurring Level 3 fair value measurements for the Company's contingent consideration liabilities related to Advantix and Resourcive at September 30, 2025 were as follows.
AcquisitionReporting PeriodValuation TechniqueSignificant Unobservable InputsWeighted Average Rates
AdvantixSeptember 30, 2025Discounted cash flowAdjusted EBITDA risk premium15.3 %
Adjusted EBITDA growth rate22.0 %
ResourciveSeptember 30, 2025Monte CarloAdjusted EBITDA risk premium12.7 %
Simulated commission growth percentage24.2 %